PTG-100 for Patients With Celiac Disease

NCT04524221 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: PTG-100
DRUG: Placebo

Sponsor

Nielsen Fernandez-Becker

Collaborators

[object Object]